Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 68 entries
Sorted by: Best Match Show Resources per page
Effect of Flos carthami Extract and α 1-Adrenergic Antagonists on the Porcine Proximal Ureteral Peristalsis.

Evidence-based complementary and alternative medicine : eCAM

Wu SY, Man KM, Shen JL, Chen HY, Chang CH, Tsai FJ, Hsieh WT, Winardi D, Lee YJ, Tsai KS, Lin YN, Chen YH, Chen WC.
PMID: 25170340
Evid Based Complement Alternat Med. 2014;2014:437803. doi: 10.1155/2014/437803. Epub 2014 Jul 09.

Traditional Chinese medicine (TCM) has been proposed to prevent urolithiasis. In China, Flos carthami (FC, also known as Carthamus tinctorius) (Safflower; Chinese name: Hong Hua/) has been used to treat urological diseases for centuries. We previously performed a screening...

Cite
Wu SY, Man KM, Shen JL, et al. Effect of Flos carthami Extract and α 1-Adrenergic Antagonists on the Porcine Proximal Ureteral Peristalsis. Evid Based Complement Alternat Med. 2014;2014:437803doi: 10.1155/2014/437803.
Wu, S. Y., Man, K. M., Shen, J. L., Chen, H. Y., Chang, C. H., Tsai, F. J., Hsieh, W. T., Winardi, D., Lee, Y. J., Tsai, K. S., Lin, Y. N., Chen, Y. H., & Chen, W. C. (2014). Effect of Flos carthami Extract and α 1-Adrenergic Antagonists on the Porcine Proximal Ureteral Peristalsis. Evidence-based complementary and alternative medicine : eCAM, 2014437803. https://doi.org/10.1155/2014/437803
Wu, San-Yuan, et al. "Effect of Flos carthami Extract and α 1-Adrenergic Antagonists on the Porcine Proximal Ureteral Peristalsis." Evidence-based complementary and alternative medicine : eCAM vol. 2014 (2014): 437803. doi: https://doi.org/10.1155/2014/437803
Wu SY, Man KM, Shen JL, Chen HY, Chang CH, Tsai FJ, Hsieh WT, Winardi D, Lee YJ, Tsai KS, Lin YN, Chen YH, Chen WC. Effect of Flos carthami Extract and α 1-Adrenergic Antagonists on the Porcine Proximal Ureteral Peristalsis. Evid Based Complement Alternat Med. 2014;2014:437803. doi: 10.1155/2014/437803. Epub 2014 Jul 09. PMID: 25170340; PMCID: PMC4120800.
Copy Download .nbib Format: NLM
Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures.

Heart international

Vinik AI, Bloom HL, Colombo J.
PMID: 27004091
Heart Int. 2014 Aug 22;9(1):7-14. eCollection 2014.

BACKGROUND: Cardiovascular autonomic neuropathy (CAN) is recognized as a significant health risk. Specific and sensitive measures of CAN are needed for early identification and treatment to avoid complications, preferably in the preclinical state.OBJECTIVES: In this first of two articles,...

Cite
Vinik AI, Bloom HL, Colombo J. Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures. Heart Int. 2014;9(1):7-14
Vinik, A. I., Bloom, H. L., & Colombo, J. (2014). Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures. Heart international, 9(1), 7-14.
Vinik, Aaron I, et al. "Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures." Heart international vol. 9,1 (2014): 7-14.
Vinik AI, Bloom HL, Colombo J. Differential effects of adrenergic antagonists (Carvedilol vs Metoprolol) on parasympathetic and sympathetic activity: a comparison of measures. Heart Int. 2014 Aug 22;9(1):7-14. eCollection 2014. PMID: 27004091; PMCID: PMC4774948.
Copy Download .nbib Format: NLM
A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction.

Therapeutic advances in urology

Hatzimouratidis K.
PMID: 25083163
Ther Adv Urol. 2014 Aug;6(4):135-47. doi: 10.1177/1756287214531639.

Epidemiological data link erectile dysfunction (ED) and benign prostatic hyperplasia (BPH)-associated lower urinary tract symptoms (LUTS), two highly prevalent conditions in aging men, assuming common pathophysiological pathways. Tadalafil 5 mg once daily has been approved for the treatment of...

Cite
Hatzimouratidis K. A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction. Ther Adv Urol. 2014;6(4):135-47doi: 10.1177/1756287214531639.
Hatzimouratidis, K. (2014). A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction. Therapeutic advances in urology, 6(4), 135-47. https://doi.org/10.1177/1756287214531639
Hatzimouratidis, Konstantinos. "A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction." Therapeutic advances in urology vol. 6,4 (2014): 135-47. doi: https://doi.org/10.1177/1756287214531639
Hatzimouratidis K. A review of the use of tadalafil in the treatment of benign prostatic hyperplasia in men with and without erectile dysfunction. Ther Adv Urol. 2014 Aug;6(4):135-47. doi: 10.1177/1756287214531639. PMID: 25083163; PMCID: PMC4054509.
Copy Download .nbib Format: NLM
Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction.

Frontiers in oncology

Repka MC, Guleria S, Cyr RA, Yung TM, Koneru H, Chen LN, Lei S, Collins BT, Krishnan P, Suy S, Dritschilo A, Lynch J, Collins SP.
PMID: 27242962
Front Oncol. 2016 May 18;6:122. doi: 10.3389/fonc.2016.00122. eCollection 2016.

BACKGROUND: Stereotactic body radiation therapy (SBRT) delivers high doses of radiation to the prostate while minimizing radiation to the adjacent critical organs. Large fraction sizes may increase urinary morbidity due to unavoidable treatment of the prostatic urethra. This study...

Cite
Repka MC, Guleria S, Cyr RA, et al. Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction. Front Oncol. 2016;6:122doi: 10.3389/fonc.2016.00122.
Repka, M. C., Guleria, S., Cyr, R. A., Yung, T. M., Koneru, H., Chen, L. N., Lei, S., Collins, B. T., Krishnan, P., Suy, S., Dritschilo, A., Lynch, J., & Collins, S. P. (2016). Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction. Frontiers in oncology, 6122. https://doi.org/10.3389/fonc.2016.00122
Repka, Michael C, et al. "Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction." Frontiers in oncology vol. 6 (2016): 122. doi: https://doi.org/10.3389/fonc.2016.00122
Repka MC, Guleria S, Cyr RA, Yung TM, Koneru H, Chen LN, Lei S, Collins BT, Krishnan P, Suy S, Dritschilo A, Lynch J, Collins SP. Acute Urinary Morbidity Following Stereotactic Body Radiation Therapy for Prostate Cancer with Prophylactic Alpha-Adrenergic Antagonist and Urethral Dose Reduction. Front Oncol. 2016 May 18;6:122. doi: 10.3389/fonc.2016.00122. eCollection 2016. PMID: 27242962; PMCID: PMC4870496.
Copy Download .nbib Format: NLM
Retrometabolic approaches for drug design and targeting.

Die Pharmazie

Bodor N.
PMID: 9266587
Pharmazie. 1997 Jul;52(7):491-4.

Retrometabolic drug design approaches incorporate targeting and metabolic considerations into the drug design process and represent a novel, systematic methodology for the design of safe, localized compounds. Two major design concepts aimed to increase the therapeutic index (the activity/toxicity...

Cite
Bodor N. Retrometabolic approaches for drug design and targeting. Pharmazie. 1997;52(7):491-4
Bodor, N. (1997). Retrometabolic approaches for drug design and targeting. Die Pharmazie, 52(7), 491-4.
Bodor, N. "Retrometabolic approaches for drug design and targeting." Die Pharmazie vol. 52,7 (1997): 491-4.
Bodor N. Retrometabolic approaches for drug design and targeting. Pharmazie. 1997 Jul;52(7):491-4. PMID: 9266587.
Copy Download .nbib Format: NLM
Possible modulatory effect of endogenous islet catecholamines on insulin secretion.

BMC endocrine disorders

Borelli MI, Gagliardino JJ.
PMID: 11696250
BMC Endocr Disord. 2001;1(1):1. doi: 10.1186/1472-6823-1-1.

BACKGROUND: The possible participation of endogenous islet catecholamines (CAs) in the control of insulin secretion was tested. METHODS: Glucose-induced insulin secretion was measured in the presence of 3-Iodo-L-Tyrosine (MIT), a specific inhibitor of tyrosine-hydroxylase activity, in fresh and precultured...

Cite
Borelli MI, Gagliardino JJ. Possible modulatory effect of endogenous islet catecholamines on insulin secretion. BMC Endocr Disord. 2001;1(1):1doi: 10.1186/1472-6823-1-1.
Borelli, M. I., & Gagliardino, J. J. (2001). Possible modulatory effect of endogenous islet catecholamines on insulin secretion. BMC endocrine disorders, 1(1), 1. https://doi.org/10.1186/1472-6823-1-1
Borelli, Maria I, and Gagliardino, Juan J. "Possible modulatory effect of endogenous islet catecholamines on insulin secretion." BMC endocrine disorders vol. 1,1 (2001): 1. doi: https://doi.org/10.1186/1472-6823-1-1
Borelli MI, Gagliardino JJ. Possible modulatory effect of endogenous islet catecholamines on insulin secretion. BMC Endocr Disord. 2001;1(1):1. doi: 10.1186/1472-6823-1-1. PMID: 11696250; PMCID: PMC59668.
Copy Download .nbib Format: NLM
alpha(2)-Adrenoceptor antagonists and propensity to take alcoholic beverages.

Behavioural pharmacology

Reid LD, Delconte JD, Amendola CA, Nichols ML, Krupsky GW, Dharia NS, Hubbell CL.
PMID: 11224300
Behav Pharmacol. 1994 Aug;5(4):485-493. doi: 10.1097/00008877-199408000-00009.

Rats were maintained on a daily regimen involving a 2h opportunity to take both water and a sweetened alcoholic beverage (12% ethanol, 0.25% saccharin). After 3 weeks on this regimen, rats regularly take substantial amounts of alcohol. After stabilization,...

Cite
Reid LD, Delconte JD, Amendola CA, et al. alpha(2)-Adrenoceptor antagonists and propensity to take alcoholic beverages. Behav Pharmacol. 1994;5(4):485-493doi: 10.1097/00008877-199408000-00009.
Reid, L. D., Delconte, J. D., Amendola, C. A., Nichols, M. L., Krupsky, G. W., Dharia, N. S., & Hubbell, C. L. (1994). alpha(2)-Adrenoceptor antagonists and propensity to take alcoholic beverages. Behavioural pharmacology, 5(4), 485-493. https://doi.org/10.1097/00008877-199408000-00009
Reid, L.D., et al. "alpha(2)-Adrenoceptor antagonists and propensity to take alcoholic beverages." Behavioural pharmacology vol. 5,4 (1994): 485-493. doi: https://doi.org/10.1097/00008877-199408000-00009
Reid LD, Delconte JD, Amendola CA, Nichols ML, Krupsky GW, Dharia NS, Hubbell CL. alpha(2)-Adrenoceptor antagonists and propensity to take alcoholic beverages. Behav Pharmacol. 1994 Aug;5(4):485-493. doi: 10.1097/00008877-199408000-00009. PMID: 11224300.
Copy Download .nbib Format: NLM
Physiological Mechanisms of Pheromonostatic Responses: effects of Adrenergic Agonists and Antagonists on Moth (Helicoverpa armigera) Pheromone Biosynthesis.

Journal of insect physiology

CAO M, YONGLIANG F, GILEADI C, RAFAELI A.
PMID: 12769910
J Insect Physiol. 1997 Mar;43(3):261-269. doi: 10.1016/s0022-1910(96)00088-1.

The adrenergic agonists octopamine, tyramine and clonidine inhibited the normal pheromonotropic action due to PBAN (pheromone biosynthesis activating neuropeptide) in incubations of intersegmental tissues that are situated between the 8th and 9th abdominal segments of the moth ovipositor tip....

Cite
CAO M, YONGLIANG F, GILEADI C, et al. Physiological Mechanisms of Pheromonostatic Responses: effects of Adrenergic Agonists and Antagonists on Moth (Helicoverpa armigera) Pheromone Biosynthesis. J Insect Physiol. 1997;43(3):261-269doi: 10.1016/s0022-1910(96)00088-1.
CAO, M., YONGLIANG, F., GILEADI, C., & RAFAELI, A. (1997). Physiological Mechanisms of Pheromonostatic Responses: effects of Adrenergic Agonists and Antagonists on Moth (Helicoverpa armigera) Pheromone Biosynthesis. Journal of insect physiology, 43(3), 261-269. https://doi.org/10.1016/s0022-1910(96)00088-1
CAO, M, et al. "Physiological Mechanisms of Pheromonostatic Responses: effects of Adrenergic Agonists and Antagonists on Moth (Helicoverpa armigera) Pheromone Biosynthesis." Journal of insect physiology vol. 43,3 (1997): 261-269. doi: https://doi.org/10.1016/s0022-1910(96)00088-1
CAO M, YONGLIANG F, GILEADI C, RAFAELI A. Physiological Mechanisms of Pheromonostatic Responses: effects of Adrenergic Agonists and Antagonists on Moth (Helicoverpa armigera) Pheromone Biosynthesis. J Insect Physiol. 1997 Mar;43(3):261-269. doi: 10.1016/s0022-1910(96)00088-1. PMID: 12769910.
Copy Download .nbib Format: NLM
Complex Regional Pain Syndrome.

Current treatment options in neurology

Yung Chung O, Bruehl SP.
PMID: 14516527
Curr Treat Options Neurol. 2003 Nov;5(6):499-511. doi: 10.1007/s11940-996-0018-6.

Complex regional pain syndrome (CRPS) is a heterogeneous disorder that falls in the spectrum of neuropathic pain disorders. It is maintained by abnormalities throughout the neuraxis (the peripheral, autonomic, and central nervous systems). The pathophysiology of CRPS is not...

Cite
Yung Chung O, Bruehl SP. Complex Regional Pain Syndrome. Curr Treat Options Neurol. 2003;5(6):499-511doi: 10.1007/s11940-996-0018-6.
Yung Chung, O., & Bruehl, S. P. (2003). Complex Regional Pain Syndrome. Current treatment options in neurology, 5(6), 499-511. https://doi.org/10.1007/s11940-996-0018-6
Yung Chung, Ok, and Bruehl, Stephen P.. "Complex Regional Pain Syndrome." Current treatment options in neurology vol. 5,6 (2003): 499-511. doi: https://doi.org/10.1007/s11940-996-0018-6
Yung Chung O, Bruehl SP. Complex Regional Pain Syndrome. Curr Treat Options Neurol. 2003 Nov;5(6):499-511. doi: 10.1007/s11940-996-0018-6. PMID: 14516527.
Copy Download .nbib Format: NLM
Hypertrophic obstructive cardiomyopathy: hemodynamic improvement with intravenous verapamil.

Texas Heart Institute journal

Roth SJ, Porter CB, Latson LA.
PMID: 15227134
Tex Heart Inst J. 1983 Jun;10(2):177-81.

We report the reduction in left ventricular outflow tract gradient following the intravenous administration of verapamil to two pediatric patients with hypertrophic obstructive cardiomyopathy. Traditional therapy with beta adrenergic antagonists was relatively contraindicated in both patients. In a 15-year-old...

Cite
Roth SJ, Porter CB, Latson LA. Hypertrophic obstructive cardiomyopathy: hemodynamic improvement with intravenous verapamil. Tex Heart Inst J. 1983;10(2):177-81
Roth, S. J., Porter, C. B., & Latson, L. A. (1983). Hypertrophic obstructive cardiomyopathy: hemodynamic improvement with intravenous verapamil. Texas Heart Institute journal, 10(2), 177-81.
Roth, S J, et al. "Hypertrophic obstructive cardiomyopathy: hemodynamic improvement with intravenous verapamil." Texas Heart Institute journal vol. 10,2 (1983): 177-81.
Roth SJ, Porter CB, Latson LA. Hypertrophic obstructive cardiomyopathy: hemodynamic improvement with intravenous verapamil. Tex Heart Inst J. 1983 Jun;10(2):177-81. PMID: 15227134; PMCID: PMC341633.
Copy Download .nbib Format: NLM
Acute Effect of Topical (beta-Adrenergic Antagonists on Normal Perimacular Hemodynamics.

Journal of glaucoma

Harris A, Shoemaker JA, Burgoyne J, Weinland M, Cantor LB.
PMID: 19920635
J Glaucoma. 1995 Feb;4(1):36-40.

PURPOSE: beta-adrenergic antagonists are the most commonly prescribed antiglaucoma medications. The nonselective beta blocker timolol has been shown to either increase or to not affect retinal blood flow, despite the suggestion that the drug may cause vasoconstriction due to...

Cite
Harris A, Shoemaker JA, Burgoyne J, et al. Acute Effect of Topical (beta-Adrenergic Antagonists on Normal Perimacular Hemodynamics. J Glaucoma. 1995;4(1):36-40
Harris, A., Shoemaker, J. A., Burgoyne, J., Weinland, M., & Cantor, L. B. (1995). Acute Effect of Topical (beta-Adrenergic Antagonists on Normal Perimacular Hemodynamics. Journal of glaucoma, 4(1), 36-40.
Harris, A, et al. "Acute Effect of Topical (beta-Adrenergic Antagonists on Normal Perimacular Hemodynamics." Journal of glaucoma vol. 4,1 (1995): 36-40.
Harris A, Shoemaker JA, Burgoyne J, Weinland M, Cantor LB. Acute Effect of Topical (beta-Adrenergic Antagonists on Normal Perimacular Hemodynamics. J Glaucoma. 1995 Feb;4(1):36-40. PMID: 19920635.
Copy Download .nbib Format: NLM
Blockade of Adrenal Medulla-Derived Epinephrine Potentiates Bee Venom-Induced Antinociception in the Mouse Formalin Test: Involvement of Peripheral β -Adrenoceptors.

Evidence-based complementary and alternative medicine : eCAM

Kang SY, Roh DH, Kim HW, Han HJ, Beitz AJ, Lee JH.
PMID: 24089621
Evid Based Complement Alternat Med. 2013;2013:809062. doi: 10.1155/2013/809062. Epub 2013 Sep 08.

The injection of diluted bee venom (DBV) into an acupoint has been used traditionally in eastern medicine to treat a variety of inflammatory chronic pain conditions. We have previously shown that DBV had a potent antinociceptive efficacy in several...

Cite
Kang SY, Roh DH, Kim HW, et al. Blockade of Adrenal Medulla-Derived Epinephrine Potentiates Bee Venom-Induced Antinociception in the Mouse Formalin Test: Involvement of Peripheral β -Adrenoceptors. Evid Based Complement Alternat Med. 2013;2013:809062doi: 10.1155/2013/809062.
Kang, S. Y., Roh, D. H., Kim, H. W., Han, H. J., Beitz, A. J., & Lee, J. H. (2013). Blockade of Adrenal Medulla-Derived Epinephrine Potentiates Bee Venom-Induced Antinociception in the Mouse Formalin Test: Involvement of Peripheral β -Adrenoceptors. Evidence-based complementary and alternative medicine : eCAM, 2013809062. https://doi.org/10.1155/2013/809062
Kang, Suk-Yun, et al. "Blockade of Adrenal Medulla-Derived Epinephrine Potentiates Bee Venom-Induced Antinociception in the Mouse Formalin Test: Involvement of Peripheral β -Adrenoceptors." Evidence-based complementary and alternative medicine : eCAM vol. 2013 (2013): 809062. doi: https://doi.org/10.1155/2013/809062
Kang SY, Roh DH, Kim HW, Han HJ, Beitz AJ, Lee JH. Blockade of Adrenal Medulla-Derived Epinephrine Potentiates Bee Venom-Induced Antinociception in the Mouse Formalin Test: Involvement of Peripheral β -Adrenoceptors. Evid Based Complement Alternat Med. 2013;2013:809062. doi: 10.1155/2013/809062. Epub 2013 Sep 08. PMID: 24089621; PMCID: PMC3781998.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 68 entries